Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!I wrote my first bullish article on Novo Nordisk A/S ( NVO ) back on December 20, 2024. I argued that NVO was punished just for the short term, and I saw itDaniel Sereda is chief investment analyst at a family office whose investments span continents and diverse ass ...